Natera
NASDAQ: NTRAFounded 2004 · Incorporated in Delaware · 5,964 employees on LinkedIn · 8 known investors
Find your way into Natera
596 people in our graph share verified history with the Natera team — schools, employers, funds. One of them is your warm intro.
Paul Kwanunlockedknows Matthew Rabinowitz · together at Stanford University (overlapped)
.jpeg)
×9knows the team · via Stanford University
×2knows the team · via Stanford University School of Engineering
Natera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions. The company serves patients, physicians, and healthcare systems across oncology, women's health, and organ health.
Founders & leadership
Natera was founded in 2004 by Matthew Rabinowitz and Jonathan Sheena.
MR
Matthew RabinowitzinCo-founder & Executive ChairmanMatthew Rabinowitz is co-founder and executive chairman of Natera, a genetics and diagnostics company specializing in cell-free DNA testing for cancer, genetic disorders, and transplant-related conditions. He has held academic positions as a consulting professor at Stanford University and visiting faculty at Harvard Medical School's Department of Genetics, and serves on the boards and advisory roles of multiple healthcare and biotech companies.
JS
Jonathan SheenainCo-Founder, Board Member
Investors · 8
Founder mafia
The Natera mafia →9 people who came through Natera went on to found or lead other companies.
Todd CozzensPast Board of DirectorsFounded UnitedHealth GroupJohn SteuartBoard of Directors (NTRA), Audit Committee, Compensation CommitteesFounded SchoolDuelsFaris SbahiData ScientistFounded Normal ComputingMatthew HillVice President, Research & DevelopmentFounded ElegenMukti ParikhSenior Data ScientistFounded zPREDICTADavid JohnsonChief Operating Officer, SVP of Research and DevelopmentFounded GigaGenMatthew RabinowitzCo-founder & Executive ChairmanFounded MyomeNathan HunkapillerVice President, R&DFounded CurvebioZoe VictorSenior Director of Business Operations & Product ManagementFounded Makerwine
Competitors · 5
by search overlapLabcorp1823 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Quest Diagnostics1331 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Myriad837 shared keywordsMyriad provides germline and tumor genomic testing across hereditary cancer, prenatal and reproductive health, prostate cancer, and pharmacogenomics for mental health medications. It supplies patients and healthcare providers with genetic screening results and AI-derived insights to inform diagnosis, risk assessment, and treatment decisions.
Nucleus Genomics771 shared keywordsNucleus provides genetic testing and analysis for couples planning pregnancy, screening for over 200 hereditary diseases, traits, and health conditions. For those undergoing IVF, the company offers embryo selection guidance to reduce disease risk and optimize traits including eye color, height, and intelligence.
Invitae741 shared keywordsInvitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life. Now part of Labcorp, the company leverages a nationwide network of patient service centers and coverage by most health plans to make genetic testing more accessible.
Companies competing with Natera for the same Google search keywords, organic and paid, via search-intersection analysis.
Acquisitions · 1
Early investors' stakes continue via these dealsForesight Diagnostics
Cancer recurrence testing platform acquired by Natera.
In the news
Natera (NTRA) Lands New Trial Partnerships, Is The Upside Already Priced In? - Simply Wall St Newssimplywall.st · Jul 2026Frequently asked questions
- What does Natera do?
- Natera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions. The company serves patients, physicians, and healthcare systems across oncology, women's health, and organ health.
- Who founded Natera?
- Natera was founded by Matthew Rabinowitz, Jonathan Sheena in 2004.
- Who are Natera's investors?
- Natera's investors include Bain Capital Life Sciences, Cheyenne Ventures, Claremont Creek Ventures, Foresite Capital, Harmony Partners, Lightspeed Venture Partners, RA Capital, Sofinnova Ventures.